Patents by Inventor Nadia Van Boxel

Nadia Van Boxel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240076391
    Abstract: The present invention relates to human CCR8 (hCCR8) binders, wherein the hCCR8 binder is cross-reactive with a non-human primate CCR8. Such binders are particularly useful for the depletion of intra-tumoural regulatory T-cells and immunotherapy in general.
    Type: Application
    Filed: December 23, 2021
    Publication date: March 7, 2024
    Inventors: Hui Qi Lu, Catelijne Stortelers, Nadia Van Boxel, Shanna Van Zwam, Jimmy Borloo, Bruno Dombrecht, Jo Van Ginderachter, Pascal Merchiers, Rosa Martin
  • Publication number: 20240052044
    Abstract: The present invention relates to human CCR8 (hCCR8) binders, wherein the hCCR8 binder is a non-blocking binder of hCCR8.
    Type: Application
    Filed: December 23, 2021
    Publication date: February 15, 2024
    Inventors: Hui Qi Lu, Catelijne Stortelers, Nadia Van Boxel, Shanna Van Zwam, Jimmy Borloo, Bruno Dombrecht, Jo Van Ginderachter, Pascal Merchiers, Rosa Martin
  • Publication number: 20240052045
    Abstract: The present invention relates to human CCR8 (hCCR8) binders, wherein the hCCR8 binder is cross-reactive with murine CCR8. Such binders are particularly useful for the depletion of intra-tumoural regulatory T-cells and immunotherapy in general.
    Type: Application
    Filed: December 23, 2021
    Publication date: February 15, 2024
    Inventors: Hui Qi Lu, Catelijne Stortelers, Nadia Van Boxel, Shanna Van Zwam, Jimmy Borloo, Bruno Dombrecht, Jo Van Ginderachter, Pascal Merchiers, Rosa Martin